The versatility and adaptation of bacteria from the genus Stenotrophomonas

Ryan, Robert P., Monchy, Sebastien, Cardinale, Massimiliano, Taghavi, Safiyh, Crossman, Lisa, Avison, Matthew B., Berg, Gabriele, van der Lelie, Daniel and Dow, J. Maxwell (2009) The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nature Reviews Microbiology, 7 (7). pp. 514-525. ISSN 1740-1526

Full text not available from this repository. (Request a copy)


The genus Stenotrophomonas comprises at least eight species. These bacteria are found throughout the environment, particularly in close association with plants. Strains of the most predominant species, Stenotrophomonas maltophilia, have an extraordinary range of activities that include beneficial effects for plant growth and health, the breakdown of natural and man-made pollutants that are central to bioremediation and phytoremediation strategies and the production of biomolecules of economic value, as well as detrimental effects, such as multidrug resistance, in human pathogenic strains. Here, we discuss the versatility of the bacteria in the genus Stenotrophomonas and the insight that comparative genomic analysis of clinical and endophytic isolates of S. maltophilia has brought to our understanding of the adaptation of this genus to various niches.

Item Type: Article
Additional Information: Funding Information: G.B. thanks C. Zachow, M. Hagemann, B. Lugtenberg and D. Egamberdieyeva; her research was supported by the Deutsche Forschungsgemeinschaft, the Austrian Science Foundation FWF and by the INTAS project 04-82-6969. Research by S.M., S.T. and D.v.d.L. was supported by the US Department of Energy, Office of Science, BER, project number KP1102010 under contract DE-AC02-98CH10886, by Laboratory Directed Research and Development funds (LDRD05-063 and LDRD09-005) and by Royalty Funds at the Brookhaven National Laboratory under contract with the US Department of Energy. M.B.A.’s work on S. maltophilia has been funded by the Wellcome Trust and the British Society for Antimicrobial Chemotherapy. R.P.R. and J.M.D. are indebted to Y. McCarthy for helpful discussions. R.P.R. and J.M.D. were supported in part by grants awarded by the Science Foundation of Ireland (SFI 03/IN3/B373 and 07/IN.1/B955 to J.M.D.). Sequencing of S. maltophilia R551-3 was performed under the auspices of the US Department of Energy’s Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract number DE-AC02-05CH11231, by Lawrence Livermore National Laboratory under contract number DE-AC52-07NA27344 and by Los Alamos National Laboratory under contract number DE-AC02-06NA25396.
Uncontrolled Keywords: microbiology,immunology and microbiology(all),infectious diseases,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2400/2404
Faculty \ School: Faculty of Science > School of Biological Sciences
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 14 May 2024 10:31
Last Modified: 20 May 2024 02:32
DOI: 10.1038/nrmicro2163

Actions (login required)

View Item View Item